Search
for
Sort by
Research 31–60 of 1000+
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Suppression of uterine and placental ferroptosis by N-acetylcysteine in a rat model of polycystic ovary syndrome
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Unmasking the Overlooked Symptoms of PCOS: Navigating Ovulatory Dysfunction, Menstrual Disorders, and Acne
- An update of polycystic ovary syndrome: causes and therapeutics options
- Testosterone: The Male Sex Hormone
- Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Androgen excess: a hallmark of polycystic ovary syndrome
- 11 Treatment of hirsutism and acne with cyproterone acetate
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Lichen Planopilaris
- The Role of Heat Shock Proteins in the Pathogenesis of Polycystic Ovarian Syndrome: A Review of the Literature
- ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Protein Kinase C as a Therapeutic Target
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma
- MiR-325-3p functions as a suppressor miRNA and inhibits the proliferation and metastasis of glioma through targeting FOXM1
- Icariside II inhibits gastric cancer progression by suppressing the Wnt/β-catenin signaling pathway
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity
- The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)
- Ursolic acid, a pentacyclic triterpene from Ochrosia elliptica Labill leaves and its role in the management of polycystic ovary syndrome (PCOS)
- Principles of chemotherapy
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Vitamin B6 promotes the activation of primordial follicles through the PI3K/Akt signaling pathway